• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon.

作者信息

Brunetto Maurizia Rossana, Oliveri Filippo, Colombatto Piero, Coco Barbara, Ciccorossi Pietro, Bonino Ferruccio

机构信息

U.O. Gastroenterologia ed Epatologia, Azienda Ospedaliera, Universitaria Pisana, Pisa, Italy.

出版信息

J Hepatol. 2003;39 Suppl 1:S164-7. doi: 10.1016/s0168-8278(03)00329-5.

DOI:10.1016/s0168-8278(03)00329-5
PMID:14708697
Abstract
摘要

相似文献

1
Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon.
J Hepatol. 2003;39 Suppl 1:S164-7. doi: 10.1016/s0168-8278(03)00329-5.
2
The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon.
J Hepatol. 2003;39 Suppl 1:S143-5. doi: 10.1016/s0168-8278(03)00327-1.
3
48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection.在慢性乙型肝炎感染中，48周聚乙二醇化干扰素α-2a在实现乙肝e抗原血清学转换方面优于24周聚乙二醇化干扰素α-2b。
Aliment Pharmacol Ther. 2006 Apr 15;23(8):1171-8. doi: 10.1111/j.1365-2036.2006.02887.x.
4
[Comparison of efficacy of pegylated interferon alfa-2a or interferon alfa-2b combination therapy with nucleus(t)ide analogues in HBeAg positive chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi. 2011 Oct;19(10):785-6.
5
Chronic hepatitis B: HBeAg seroconversion after pegylated interferon and nucleos(t)ide analogs.慢性乙型肝炎：聚乙二醇干扰素和核苷（酸）类似物治疗后的HBeAg血清学转换
Hepatology. 2005 Dec;42(6):1459; author reply 1459-60. doi: 10.1002/hep.20951.
6
Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study.核苷（酸）类似物序贯治疗对聚乙二醇干扰素治疗部分应答的 HBeAg 阳性慢性乙型肝炎患者的疗效：一项初步研究。
J Viral Hepat. 2013 Apr;20 Suppl 1:52-7. doi: 10.1111/jvh.12064.
7
[Pharmacological agents for the treatment of chronic hepatitis B].[用于治疗慢性乙型肝炎的药物制剂]
Gastroenterol Hepatol. 2008 Mar;31(3):120-8. doi: 10.1157/13116500.
8
Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?在聚乙二醇干扰素α-2a基础上加用拉米夫定能否维持HBeAg阴性乙型肝炎的应答率？
Nat Clin Pract Gastroenterol Hepatol. 2005 Jan;2(1):12-3. doi: 10.1038/ncpgasthep0068.
9
Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.聚乙二醇干扰素和拉米夫定治疗HBeAg阳性的乙型肝炎
N Engl J Med. 2005 Oct 13;353(15):1630-1; author reply 1630-1.
10
The Predictive Value of Baseline HBsAg Level and Early Response for HBsAg Loss in Patients with HBeAg-positive Chronic Hepatitis B during Pegylated Interferon Alpha-2a Treatment.聚乙二醇化干扰素α-2a治疗HBeAg阳性慢性乙型肝炎患者时，基线HBsAg水平及早期应答对HBsAg消失的预测价值
Biomed Environ Sci. 2017 Mar;30(3):177-184. doi: 10.3967/bes2017.025.

引用本文的文献

1
Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.乙型肝炎病毒感染的管理：加拿大肝病研究协会和加拿大医学微生物学与传染病协会2018年指南。
Can Liver J. 2018 Dec 25;1(4):156-217. doi: 10.3138/canlivj.2018-0008. eCollection 2018 Fall.
2
Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine.慢性乙型肝炎患者的管理与治疗：迈向个体化医学。
Viruses. 2022 Mar 28;14(4):701. doi: 10.3390/v14040701.
3
Breakthroughs and challenges in the management of pediatric viral hepatitis.
儿科病毒性肝炎管理的突破与挑战。
World J Gastroenterol. 2021 May 28;27(20):2474-2494. doi: 10.3748/wjg.v27.i20.2474.
4
Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.细胞因子介导的乙型肝炎病毒感染免疫发病机制
Clin Rev Allergy Immunol. 2016 Feb;50(1):41-54. doi: 10.1007/s12016-014-8465-4.
5
Mutation profiling of the hepatitis B virus strains circulating in North Indian population.在北印度人群中传播的乙型肝炎病毒株的突变谱分析。
PLoS One. 2014 Mar 17;9(3):e91150. doi: 10.1371/journal.pone.0091150. eCollection 2014.
6
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.慢性乙型肝炎的管理：加拿大肝脏研究协会共识指南
Can J Gastroenterol. 2012 Dec;26(12):917-38. doi: 10.1155/2012/506819.
7
The management of chronic viral hepatitis: A Canadian consensus conference 2004.慢性病毒性肝炎的管理：2004 年加拿大共识会议。
Can J Infect Dis Med Microbiol. 2004 Nov;15(6):313-26. doi: 10.1155/2004/326964.
8
Management of chronic hepatitis B: consensus guidelines.慢性乙型肝炎的管理：共识指南
Can J Gastroenterol. 2007 Jun;21 Suppl C(Suppl C):5C-24C.